V · NYSE
Consensus is Buy, with all 30 supplied analysts backing that rating. The stated mean price target is $420, but the low and high targets are unavailable, so the target cluster and overall spread cannot be determined. The evidence also does not identify the most or least bullish analyst. The only explicit recent revision is constructive: Truist raised its target to $371 from $361, although the snippet supplies no date or analyst name. Beyond that increase, the evidence does not establish a broader direction for weekly revisions. The substantive disagreement is therefore not quantified; available material contrasts confidence in Visa’s growth and fraud-protection expansion with uncertainty over acquisition returns and valuation.